Project

MHLW-Supported “One Stop Service Platform” ENSEMBLExJ Project

To all people involved in new drug development worldwide:

• We are keeping a close eye on your products!
• Why not consider expanding your business into Japan?
• We will provide you with the best support!

You may consider it extremely difficult and impractical to enter the Japanese market without establishing a base in Japan. In a sense, that view is correct. However, now we have launched the ‘ENSEMBLExJ Project’ with the support of the MHLW to assist such overseas companies.

We can support you in four key areas: (1) Development strategies aligned with Japan's medical and market needs, (2) Regulatory strategies for obtaining approvals, (3) Business entry strategies for the Japanese market, and (4) Funding strategies for activities in Japan. Your innovative new drug is vital for Japanese patients. Furthermore, regulatory approval in Japan is highly effective for expansion across the Asian region.

We have established the optimal working model with various Japanese experts to support you. Why not have a chat with us? You're sure to find it worthwhile!

We look forward to hearing from you.

• 
• 

ensemblexj●ml.res.ncc.go.jp（●を＠に置き換えてください）